MedPath

Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.

Phase 4
Not yet recruiting
Conditions
Miscarriage Threatening
Interventions
Drug: Duphastone
Registration Number
NCT05542797
Lead Sponsor
Konya Meram State Hospital
Brief Summary

In this study, we aimed to compare the effects of two drugs used for the threated miscarriage on the miscarriage rate.

Detailed Description

About 140 pregnant women who applied to our clinic due to the threated miscarriage in the first trimester will be randomly given micronized progesterone to half and dydrogesterone to the other half. After the treatment, the miscarriage rates in the groups will be compared.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
140
Inclusion Criteria
  • pregnant women with threated miscarriage in the first trimester.
Exclusion Criteria
    • pregnant women with abortus incipiens.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
DydrogesteroneDuphastoneDydrogesterone will be given to 70 pregnant women with threated miscarriage.
Micronised progesteroneDuphastoneMicronized progesterone will be given to 70 pregnant women with threated miscarriage.
Primary Outcome Measures
NameTimeMethod
Miscarriage rateOne year

Effects of two drugs to be used on live birth rate in pregnant women with threated miscarriage

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath